Clinical trials: Allergic Rhinitis (Disorder)
Asthma, Allergic Rhinitis
Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma
Double blind protocol treatment of 2/3 of the patients with omalizumab and 1/3 placebo administer for 4 months. Patients selected for the study must have both aspirin exacerbated respiratory disease and allergic asthma and…
- Trial name
- NCT00286416
- Testing
- omalizumab (Xolair)
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- Scripps Clinic
Non-allergic Rhinitis.
Kinetic Oscillation Stimulation (KOS) of Nasal Mucosa in Non-allergic Rhinitis: Investigation of Treatment Procedure
The purpose of the study is to evaluate how treatment with Kinetic Oscillation Stimulation (KOS) in the nasal cavity in patients with non-allergic rhinitis can be optimized to minimize any patient reported discomfort during…
- Trial name
- NCT02136043
- Testing
- PBASE system 1.1 (active treatment)
- Where
- Sweden
- Volunteers
- 29 people
- Sponsor
- Halmstad County Hospital
Allergy, Respiratory Disease
Impact of AIT on Allergic Rhinitis and Asthma
The study will assess the effectiveness of AIT treatment in real clinical practice in Germany.
- Trial name
- NCT04125888
- Testing
- Allergy immunotherapy (AIT)
- Where
- Denmark
- Volunteers
- 92,048 people
- Sponsor
- ALK-Abelló A/S
Type I Hypersensitivity
Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy
Ragweed MATAMPL has been developed to provide pre-seasonal specific immunotherapy for patients with hypersensitivity to ragweed pollen (hay fever).
- Trial name
- NCT00110786
- Testing
- Ragweed MATAMPL
- Where
- Canada
- Volunteers
- 240 people
- Sponsor
- Allergy Therapeutics
Allergic Rhinitis
ATIBAR - Efficacy and Safety of Two Doses of AllerT in Patients Allergic to Birch Pollen
A multicentre, Double-blind, Placebo-Controlled, Randomized Trial to Assess the Efficacy and Tolerability of Two Dosing Regimens of AllerT, a Combination of Contiguous Overlapping Peptides Derived from Bet v 1, in Adults with…
- Trial name
- ATIBAR (NCT02943720)
- Testing
- AllerT
- Where
- 36 sites in Denmark, Finland and 6 more
- Volunteers
- 421 people
- Sponsor
- Anergis
Rhinitis
Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES)
The purpose of this trial is to determine if patients with NARES treated with montelukast (Singulair) will have improved nasal symptom scores and reduced nasal eosinophils.
- Trial name
- NCT00406094
- Testing
- montelukast
- Where
- United States
- Volunteers
- 6 people
- Sponsor
- Bernstein, Jonathan A., M.D.
Seasonal Allergic Rhinitis
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies
The purpose of this study is to determine if one allergy medication (0.15% azelastine hydrochloride) is more effective than Placebo alone
- Trial name
- NCT00824473
- Testing
- 0.15% azelastine hydrochloride
- Where
- 7 sites in United States
- Volunteers
- 506 people
- Sponsor
- Meda Pharmaceuticals
Seasonal Allergic Rhinitis
A Multicenter, Randomized, Double-blind, Three-arm, Parallel Clinical Endpoint Bioequivalence Study of Monometasone Furoate Nasal Spray in Patients With Seasonal Allergic Rhinitis
Taking the mamsonic acid nasal spray held by Zhejiang Xianxian Pharmaceutical Technology Co., Ltd. as the test agent,Bannicate nose spray (product name: inside: insideSchuro®) is a reference preparation.
- Trial name
- NCT06200766
- Testing
- Mometasone furoate as a nasal spray
- Where
- China
- Volunteers
- 640 people
- Sponsor
- Zheng Liu ENT
Allergic Rhinitis
Effect of Air Cleaner on the Indoor Allergen Sensitized Allergic Rhinitis Patients
This study aimed to assess the impact of air cleanser on allergic rhinitis patients and indoor air quality. Air cleaners will be installed in the bedrooms and living rooms of the mite allergic rhinitis patients who aged 18-60…
- Trial name
- NCT03313453
- Testing
- PuriCare (HEPA Air Cleaner), Mock device of PuriCare
- Where
- South Korea
- Volunteers
- 44 people
- Sponsor
- Yonsei University
Allergic Rhinitis
EVALUATION OF THE EFFECTIVENESS AND SAFETY OF DOSPRAY® NAZAL SPRAY IN THE SYMPTOMATIC TREATMENT OF PERSISTENT ALLERGIC RHINITIS: A POST-REGISTRATION OBSERVATION STUDY
The combined use of dexamethasone and oxymetazoline has a vasoconstrictive, anti-inflammatory and anti-allergic effect when applied topically in diseases of the upper respiratory tract.
- Trial name
- NCT05896241
- Testing
- non-interventional study
- Where
- 2 sites in Kazakhstan
- Volunteers
- 126 people
- Sponsor
- LeKos LLP
Allergic Rhinitis
Benjakul Extract and Loratadine for Treatment Allergic Rhinitis Patients
1. To compare the effectiveness of Benjakul extract capsules at 300 mg per day with Loratadine drug in the treatment of allergic rhinitis patients in small group (Clinical Trial Phase II). 2.
- Trial name
- NCT03376594
- Testing
- Benjakul Extract, Loratadine
- Where
- Thailand
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Thammasat University
Allergic Rhinitis
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic Rhinitis
This is a Phase Ib, randomized, blinded, placebo-controlled, multiple-ascending dose study in patients with seasonal or perennial allergic rhinitis to investigate the safety, tolerability, and pharmacokinetics (PK) of MEMP1972A.
- Trial name
- NCT01160861
- Testing
- MEMP1972A
- Volunteers
- 36 people
- Sponsor
- Genentech, Inc.
Perennial Allergic Rhinitis
Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis
The purpose of this study is to evaluate of efficacy and safety of mometasone furoate plus azelastine HCl in patients with perennial allergic rhinitis.
- Trial name
- NCT01470053
- Testing
- mometasone furoate plus azelastine HCl, mometasone furoate, azelastine HCl
- Where
- South Korea
- Volunteers
- 347 people
- Sponsor
- Hanlim Pharm. Co., Ltd.
Rhinitis, Allergic, Perennial
A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).
The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with…
- Trial name
- NCT00103454
- Testing
- GW685698X
- Where
- 49 sites in United States, Canada
- Volunteers
- 288 people
- Sponsor
- GlaxoSmithKline
Perennial Allergic Rhinitis With Seasonal Variation
The Efficacy & Safety of the UAS Immunotherapy Protocol
Hypothesis: The UAS Immunotherapy protocol is efficacious and at least as efficacious as protocols described in the Allergy literature.
- Trial name
- NCT01699659
- Testing
- allergen immunotherapy
- Where
- United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- United Allergy Services
Allergic Rhinitis
Intranasal CO2 for Allergic Rhinitis
The purpose of this study is to better understand the way in which CO2 (carbon dioxide) affects the symptoms of allergic rhinitis or hayfever.
- Trial name
- NCT00618410
- Testing
- Carbon dioxide, USP
- Where
- United States
- Volunteers
- 13 people
- Sponsor
- University of Chicago
Dust Mite Allergy, Allergic Rhinitis
Impact of a Novel Immune Modulating Dietary Supplement on House Dust Mite Induced Allergic Rhinoconjunctivitis
A validated mobile Allergen exposure chamber (AEC) is used to expose qualified study participants suffering from house dust mite (HDM) induced allergic rhinoconjunctivitis.
- Trial name
- NCT04477382
- Testing
- holo-BLG (beta-lactoglobulin) - a major component of the protein fraction of raw milk, is loaded with ligands such as retinoic acid, zinc and polyphenol-iron complexes.
- Where
- Germany
- Volunteers
- 38 people
- Sponsor
- Ecarf Institute GmbH
Perennial Allergic Rhinitis
A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis
The purpose of this study is to determine if one allergy treatment (0.15% azelastine hydrochloride) is as safe as mometasone furoate (nasonex) alone.
- Trial name
- NCT00720382
- Testing
- 0.15% azelastine hydrochloride, Mometasone furoate
- Where
- 59 sites in United States
- Volunteers
- 703 people
- Sponsor
- Meda Pharmaceuticals
Nasal Congestion
To Determine if Diphenhydramine Works for Nasal Congestion at Two Different Doses
The study was to determine if the drug worked to relieve nasal congestion experienced by people with seasonal allergies.
- Trial name
- NCT00648973
- Testing
- Diphenhydramine 50 mg, Diphenhydramine 25 mg, Pseudoephedrine 120 mg
- Where
- 12 sites in United States
- Volunteers
- 1,021 people
- Sponsor
- Johnson & Johnson Consumer and Personal Products Worldwide
Rhinitis, Allergic, Seasonal
Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen
Questionnaire to measure and control the quality of life of patients with hay fever who are treated or were treated with Pollinex quattro
- Trial name
- NCT03014661
- Testing
- Quality of life under or after therapy with Pollinex quattro
- Where
- Germany
- Volunteers
- 58 people
- Sponsor
- Universität des Saarlandes
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.